Abstract
CD1, a conserved family of major histocompatibility (MHC)-like glycoproteins in mammals, specializes in capturing lipid rather than peptide antigen for presentation to T lymphocytes. The principles and mechanisms of this newly discovered immune strategy differ markedly from those governing classical MHC-peptide presentation. They might be exploited for the design of new lipid-based microbial vaccines and adjuvants.
Original language | English |
---|---|
Pages (from-to) | 788-792 |
Number of pages | 5 |
Journal | Nature |
Volume | 406 |
Issue number | 6797 |
DOIs | |
Publication status | Published - 2000 Aug 17 |
Externally published | Yes |
ASJC Scopus subject areas
- General